|
|
|
| |
|
|
| |
The latest stem cells news from News Medical |
|
|
|
 | | |
 Sustainable Alternative: A New Standard in Endotoxin Detection
Traditional LAL testing relies on horseshoe crab blood and is prone to interference from β-glucans. The SAFENSURE™ Recombinant Factor C (rFC) Endotoxin Detection Kit offers a sustainable, animal-free alternative with no β-glucan false positives and excellent lot-to-lot consistency. With high sensitivity and regulatory alignment, rFC offers a reliable, eco-friendly solution for modern endotoxin testing.
| |
|
|
|  | | | | |  UC Irvine receives funding for clinical trial of neural stem cell therapy for Huntington's disease Leslie M. Thompson, Donald Bren Professor of psychiatry and human behavior as well as neurobiology and behavior at the University of California, Irvine, has received an $11,999,933 grant from the California Institute for Regenerative Medicine for an unprecedented clinical trial of a novel neural stem cell therapy for Huntington's disease. | |  | | | | |  Lysophosphatidylcholines show gene-dependent effects in early Alzheimer’s disease A new study presents robust evidence on the role of lysophosphatidylcholines (LPCs) in the onset of Alzheimer's disease. Researchers discovered that LPCs-compounds that transport a variety of healthy fatty acids to the brain-either promote Alzheimer's or protect against it, depending on a person's genetics. | | | | | | |  SN101 iPSC-derived therapy relieves chronic pain and preserves joints SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on a novel approach to chronic pain management and joint tissue preservation. | | | | | | |  First-of-its-kind mRNA system switches on therapeutic genes inside targeted cells Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells-an advance demonstrated in studies in mice that could lay the groundwork for safer, more precise treatments for cancer and other diseases. | | | | | | |  Researchers identify chromatin accessibility changes driving stem cell transformation in MDS Over the past few decades, advances in hematology have illuminated how a delicate balance between stem cell self-renewal and differentiation sustains healthy blood formation. | |
|
|
| | | | How would you rate today's newsletter?
| |
|
|
| | | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|
|
|
|
